drugset / Trial / NCT01134107

Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use

NCT01134107

Phase 3 Completed 133 enrolled Eli Lilly and Company
RandomizedCrossoverTriple-blindTreatment

Summary

Patients will continue to use their current insulin pump for this study. Patients will receive insulin lispro and insulin aspart during this study. One medication will be taken for 12 weeks and then the other medication for 12 weeks. Neither the patient nor the study doctor will know which medication is being taken at any time. The order in which the two medications are taken will be determined by chance.

Timeline

Start
2010-11
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Protein / enzyme biologic Other
Comparator insulin aspart Protein / enzyme biologic Other